Sun Pharmaceutical Industries Ltd share price logo

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA

BSE: 524715

Large Cap

Healthcare Sector

Pharma Sector

₹1944.60

+0.20

(+0.01%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Sun Pharmaceutical Industries Stock Performance

as on August 11, 2026 at 3:50 pm IST

  • Day's Low

    Day's High

    ₹1,936.50
    ₹1,951.10
    downward going graph

    0.42%

    Downside

    0.33%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,548.00
    ₹2,046.90
    downward going graph

    20.39%

    Downside

    5.26%

    Upside

    downward going graph

Sun Pharmaceutical Industries share price movements today

Previous Close
₹1,944.40
Open
₹1,944.50
Volume
2.91L
Upper Circuit
₹2,138.80
Lower Circuit
₹1,750.00
Day's Low - High
₹1,936.50 - ₹1,951.10
52 Week Low - High
₹1,548.00 - ₹2,046.90

Sun Pharmaceutical Industries Historical Returns

1 Month Return
+ 1.2 %
3 Month Return
+ 3.83 %
1 Year Return
+ 20.89 %
3 Year Return
+ 71.71 %
5 Year Return
+ 149.43 %

Sun Pharmaceutical Industries Fundamentals

as on August 11, 2026 at 10:20 am IST

Market Cap

₹4,66,526.69 Cr

Return on Equity (ROE)

12.73

PE Ratio (TTM)

0

Return on capital employed (ROCE)

14.47

Industry PE ratio

-

Beta (LTM)

0.48

P/B Ratio

18.85

Dividend Yield

0.91

PEG Ratio

0

Quarterly Earnings Growth YOY

26.41

EPS (TTM)

48.2

Book Value

348.31

Sun Pharmaceutical Industries Technical Analysis

Track how Sun Pharmaceutical Industries technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish8
Bullish2
Neutral5

Oscillators

Name

Value

Action

MACD level (12,26)
-0.6
Bullish
CCI (20)
14.76
Neutral
RSI (14)
46.86
Neutral
Momentum (10)
1.4
Neutral
ADI (14)
22.63
Neutral
Ultimate Oscillator (7,14,28)
53.33
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1943.53
Bearish
EMA (20)
1943.73
Bearish
VWMA (20)
1943.21
Bullish
SMA (50)
1945.1
Bearish
EMA (50)
1944.44
Bearish
SMA (200)
1947.17
Bearish
EMA (200)
1946.14
Bearish
KAMA (200)
1943.55
Bearish
DEMA (200)
1945.02
Bearish

Sun Pharmaceutical Industries Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sun Pharmaceutical Industries with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sun Pharmaceutical Industries Ltd image
Sun Pharmaceutical Industries Ltd
BUY4,66,526.6929.89%0.5411,56458,462
Divis Laboratories Ltd image
Divis Laboratories Ltd
HOLD2,20,338.9213.75%0.522,56810,560
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,87,293.1347.87%0.872,13819,274
Biocon Ltd image
Biocon Ltd
HOLD69,441.272.87%0.6836816,927
Gland Pharma Ltd image
Gland Pharma Ltd
BUY44,001.56-7.15%0.521,0276,430
See all

Market expectation of Sun Pharmaceutical Industries Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

87.88%

Buy

3.03%

Hold

9.09%

Sell

Sun Pharmaceutical Industries Stock’s Investor Sentiment and Interest

Investment in Sun Pharmaceutical Industries Ltd Shares on INDmoney has dropped by -14.20% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-14.20% versus previous 30 day period

Search interest for Sun Pharmaceutical Industries Ltd Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-5% versus previous 30 day period

Sun Pharmaceutical Industries Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
12,003.11
12,156.86
11,813.33
12,524.51
13,264.22
13,436.94
12,815.58
13,786.07
14,405.22
15,469.07
14,559.75
15,183.55
Other Income
293.61
250.2
605.94
532.55
354
465.62
612.87
464.46
469.92
578.84
458.5
723.62
Total Income
12,486.02
12,630.9
12,588.84
13,185.3
13,645.39
14,141.08
13,571.71
14,315.86
14,948.23
16,099.38
15,070.29
16,023.5
Expenses
9,013.03
8,973.68
9,049.39
9,045.13
9,352.43
9,982.61
9,604.43
10,367.74
9,951.26
11,061.53
10,657.59
11,086.3
Operating Profit
2,990.08
3,183.18
2,763.94
3,479.38
3,911.79
3,454.33
3,211.15
3,418.33
4,453.96
4,407.54
3,902.16
4,097.25
Operating Profit Margin %
24.91%
26.18%
23.4%
27.78%
29.49%
25.71%
25.06%
24.8%
30.92%
28.49%
26.8%
26.98%
Profit Before Interest, Tax and Depreciation
3,472.99
3,657.22
3,539.45
4,140.17
4,292.96
4,158.47
3,967.28
3,948.12
4,996.97
5,037.85
4,412.7
4,937.2
Interest
49.29
34.73
73.57
61.54
69.17
51.51
49.14
74.8
99.86
78.36
85.89
99.67
Depreciation
632.82
622.14
650.36
655.13
625.91
630.56
663.79
700.55
729.5
732.33
775.47
738.72
Profit Before Tax
2,790.88
3,000.35
2,815.52
3,423.5
3,597.88
3,476.4
3,254.35
3,172.77
4,167.61
4,227.16
3,551.34
4,098.81
Tax Paid
390.1
432.32
148.93
552.25
567.21
558.86
1,093.71
870.15
1,030.52
826.07
827.62
1,188.01
Profit After Tax
2,400.78
2,568.03
2,666.59
2,871.25
3,030.67
2,917.54
2,160.64
2,302.62
3,137.09
3,401.09
2,723.72
2,910.8
Total Net profit including share of profit / Loss from associate company
2,385.1
2,560.54
2,658.74
2,860.51
3,037.33
2,912.98
2,153.93
2,292.87
3,124.95
3,381.17
2,709.66
2,901.23
EPS
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
12.1
Actual EPS
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
12.1
Adjusted EPS
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
12.1
Diluted EPS
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
12.1

Sun Pharmaceutical Industries Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
26,065.94
28,686.28
32,325.17
33,233.08
38,426.42
43,278.87
47,758.45
52,041.25
58,220.11
Other Income
838.76
1,025.49
635.98
835.52
921.51
634.52
1,354.19
1,965.04
1,971.72
Total Income
27,328.22
30,091.4
33,473.48
34,333.66
39,576
44,520.2
49,851.04
54,543.48
60,433.76
Expenses
21,831.83
23,972.7
26,108.38
29,312.91
32,823.59
32,410.34
35,968.04
37,984.6
42,038.12
Operating Profit
4,234.11
4,713.58
6,216.79
3,920.17
5,602.83
10,868.53
11,790.41
14,056.65
16,181.99
Operating Profit Margin %
16.24%
16.43%
19.23%
11.8%
14.58%
25.11%
24.69%
27.01%
27.79%
Profit Before Interest, Tax and Depreciation
5,496.39
6,118.7
7,365.1
5,020.75
6,752.41
12,109.86
13,883
16,558.88
18,395.64
Interest
517.57
555.25
302.73
141.43
127.35
172
238.47
231.36
338.91
Depreciation
1,499.84
1,753.25
2,052.78
2,079.95
2,143.74
2,529.43
2,556.64
2,575.39
2,937.85
Profit Before Tax
3,478.98
3,810.2
5,009.59
2,799.37
4,481.32
9,408.43
11,087.89
13,752.13
15,118.88
Tax Paid
911.04
600.88
822.8
514.69
1,075.5
847.59
1,439.45
2,772.03
3,554.36
Profit After Tax
2,567.94
3,209.32
4,186.79
2,284.68
3,405.82
8,560.84
9,648.44
10,980.1
11,564.52
Total Net profit including share of profit / Loss from associate company
2,542.5
3,207.86
4,171.96
2,272.35
3,389.28
8,512.94
9,610.03
10,964.75
11,508.65
EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8
Actual EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8
Adjusted EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8
Diluted EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8

Sun Pharmaceutical Industries Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
6,685.86
7,082.21
3,907.15
2,196.45
6,554.77
6,170.37
8,984.54
4,959.33
12,134.98
14,072.09
12,419.18
Cash Flow from Investing Activities
-3,949.13
-4,186.15
-3,103.8
-310.08
-2,225.32
406.53
-5,555.86
-7,219.92
-762.9
-5,183.15
-10,404.89
Cash Flow from Financing Activities
-1,888.53
-2,285.39
-1,539.26
-2,730.52
-5,715.14
-5,980.48
-5,193.46
2,376.07
-6,710.16
-7,905.82
-2,512.55
Net Cash Flow
848.2
610.67
-735.91
-844.15
-1,385.69
596.42
-1,764.78
115.48
4,661.92
983.12
-498.26

Sun Pharmaceutical Industries Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
DII
19.67%
17.97%
18.83%
19.28%
18.61%
18.55%
18.7%
19.5%
20.23%
20.82%
21.11%
22.18%
FII
16.79%
0%
17.72%
17.23%
18.02%
18.05%
17.96%
17.26%
16.55%
16.12%
15.93%
14.53%
Public
9.06%
8.92%
8.97%
9.01%
8.89%
8.92%
8.87%
8.77%
8.73%
8.58%
8.48%
8.81%
Total Outstanding Shares
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
Total Shareholders
6,16,588
6,12,626
6,31,392
6,73,217
6,57,317
6,89,623
7,04,983
7,23,770
7,43,877
7,10,900
6,90,957
7,10,246

Mutual Funds that own Sun Pharmaceutical Industries Stock

Check out the Mutual Funds with significant holdings in Sun Pharmaceutical Industries.

Sun Pharmaceutical Industries Corporate Actions

View detailed summary of the earnings and dividend history of Sun Pharmaceutical Industries.

  • Sun Pharmaceutical Industries Ltd Earnings Results

    Sun Pharmaceutical Industries Ltd’s net profit jumped 27.04% since last year same period to ₹2,894.79Cr in the Q1 2026-2027. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 6.66% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Sun Pharmaceutical Industries Ltd Dividends May,2026

    In the quarter ending March 2026, Sun Pharmaceutical Industries Ltd has declared dividend of ₹5.00 per share on 22 May 2026 - translating a dividend yield of 1.11%.

    Read More about Dividends

Indices Featuring Sun Pharmaceutical Industries Stock

Check stock indices that include Sun Pharmaceutical Industries.

SENSEX

₹78,130.15

-412.29 (▲0.52%)

BSE MFG

₹1,108.63

-0.52 (▲0.05%)

S&P BSE 100 ESG

₹416.48

-1.58 (▲0.38%)

Nifty100 Low Volatility 30

₹20,610.35

-84.15 (▲0.41%)

S&P BSE Dividend Stability

₹1,052.66

-1.56 (▲0.15%)

BSE 200

₹11,486.38

-42.52 (▲0.37%)

Nifty 200

₹14,198.75

-56.85 (▲0.40%)

Nifty100 Eq Weig

₹35,519.80

-109.90 (▲0.31%)

Nifty LargeMidcap 250

₹16,947.85

-49.35 (▲0.29%)

BSE 100

₹26,194.25

-96.27 (▲0.37%)

NIFTY 100

₹25,611.50

-116.80 (▲0.45%)

NIFTY PHARMA

₹26,484.15

4.60 (▲0.02%)

NIFTY 50

₹24,465.85

-117.95 (▲0.48%)

S&P BSE 250 LargeMidCap

₹10,948.19

-37.77 (▲0.34%)

S&P BSE 100 LargeCap TMC

₹9,239.59

-36.48 (▲0.39%)

S&P BSE SENSEX 50

₹25,697.42

-111.76 (▲0.43%)

S&P BSE Low Volatility

₹1,800.50

-6.95 (▲0.38%)

Nifty Healthcare

₹16,587.15

-63.80 (▲0.38%)

BSE Healthcare

₹51,148.02

-40.95 (▲0.08%)

Nifty 500

₹23,665.65

-77.55 (▲0.33%)

BSE 500

₹37,024.76

-107.21 (▲0.29%)

Insights on Sun Pharmaceutical Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 15.07K Cr → 16.02K Cr (in ₹), with an average increase of 6.0% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 11.96% to 12.84% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, SUNPHARMA stock has moved up by 13.9%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 8.48% to 8.81% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 2.71K Cr → 2.89K Cr (in ₹), with an average increase of 6.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 142.5% return, outperforming this stock by 73.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 38.1% return, outperforming this stock by 17.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.48% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 15.93% to 14.53% in Jun 2026 quarter

Sun Pharmaceutical Industries Stock Futures & Options Contracts

View the latest movement in Sun Pharmaceutical Industries Futures & Options, including strike prices, expiry dates, and percentage changes.

Sun Pharmaceutical Industries Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 25 Aug ₹1980 Call
August 25, 2026
₹1980
₹17.7
-1.95
-9.92%
SUNPHARMA 25 Aug ₹2000 Call
August 25, 2026
₹2000
₹12.05
-1.55
-11.4%
SUNPHARMA 25 Aug ₹1960 Call
August 25, 2026
₹1960
₹25.5
-2.2
-7.94%
SUNPHARMA 25 Aug ₹1900 Call
August 25, 2026
₹1900
₹63
-1.75
-2.7%

Sun Pharmaceutical Industries Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 25 Aug Fut
August 25, 2026
-
₹1951.2
-1.17
-0.06%
SUNPHARMA 29 Sep Fut
September 29, 2026
-
₹1963.4
-1.18
-0.06%
SUNPHARMA 27 Oct Fut
October 27, 2026
-
₹1976.1
3.94
0.2%

About Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd., incorporated in 1983, is a global specialty generic pharmaceuticals company with a presence in over 150 countries. The company is headquartered in Mumbai, India, and has operations in three primary lines of business: branded formulations, specialty generics, and active pharmaceutical ingredients (API).

Sun Pharma's branded formulations include products for cardiovascular, central nervous system, gastroenterology, ophthalmology, and dermatology. Sun Pharma's specialty generics include injectables, inhalants, and complex products. Sun Pharma's API portfolio includes products for a range of therapeutic areas, including cardiovascular, central nervous system, gastroenterology, and dermatology.

Sun Pharma's top products include Modalert, a generic version of Modafinil for treating sleep disorders; Glocip, a generic version of Glipizide for treating diabetes; and Doxicip, a generic version of Doxycycline for treating bacterial infections. Sun Pharma's popular brands include Revital, a multivitamin supplement; Tazret, a topical retinoid for treating psoriasis; and Olmecip, a generic version of Olmesartan for treating hypertension.

Revenue: ₹15,183.55Cr as on June 2026 (Q1 FY27)
Net Profit: ₹2,910.80Cr as on June 2026 (Q1 FY27)
Listing date: 08 Feb, 1995
Revital Share Price
Volini Share Price
Abzorb Share Price
Pepfiz Share Price
OrganisationSun Pharmaceutical Industries Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Sun Pharmaceutical Industries share price today?

Sun Pharmaceutical Industries share price today stands at ₹1944.6 as on . Sun Pharmaceutical Industries share today touched a day high of ₹1951.1 and a low of ₹1936.5.

What is the 52 week high and 52 week low range for Sun Pharmaceutical Industries share?

Sun Pharmaceutical Industries touched a 52 week high of ₹2046.9 and a 52 week low of ₹1548. Sun Pharmaceutical Industries share price today i.e. is trending at ₹1944.6, which is -5.00% down from its 52 week high and 25.62% up from its 52 week low.

What is Sun Pharmaceutical Industries's market capitalisation today?

Sun Pharmaceutical Industries market capitalisation is ₹4,66,526.69 Cr as on .

How to buy Sun Pharmaceutical Industries shares?

To buy Sun Pharmaceutical Industries shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUNPHARMA or Sun Pharmaceutical Industries Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sun Pharmaceutical Industries shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sun Pharmaceutical Industries trading volume today?

Sun Pharmaceutical Industries trading volume is 2.91L as on . This means that 2.91L shares of Sun Pharmaceutical Industries were bought and sold on the stock market during today's trading session.